Squarepoint’s HilleVax HLVX Stock Holding History

Squarepoint’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-61,997	Closed	-$123K	–	4612
2025 Q2	$123K	Buy	61,997 +42,142	+212%	+$77.1K	﹤0.01%	4115
2025 Q1	$28.8K	Buy	+19,855	New	+$36.7K	﹤0.01%	4412
2024 Q4	–	Sell	-38,967	Closed	-$68.6K	–	5214
2024 Q3	$68.6K	Buy	+38,967	New	+$99.9K	﹤0.01%	3943
2022 Q3	–	Sell	-18,368	Closed	-$201K	–	3172
2022 Q2	$201K	Buy	+18,368	New	+$218K	﹤0.01%	2476

Squarepoint's HLVX Position: Q3 2025 in Review

Squarepoint sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 61,997 shares — an estimated $123K sold.

Squarepoint first reported a position in HLVX in Q2 2022 and held it in 4 quarters. The position peaked at $201K in Q2 2022. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

Squarepoint reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
Squarepoint sold 61,997 HilleVax shares in Q3 2025, an estimated $123K.
Squarepoint first reported a position in HilleVax in Q2 2022 and held it in 4 quarters.
Squarepoint's HilleVax position peaked at $201K in Q2 2022.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.